Our mRNA research services offer you an easy approach to simplify and accelerate your mRNA/LNP project. Learn more today about our early development services for mRNA and its encapsulation in lipid nanoparticles (LNPs).
You may also be interested in:
mRNA
Injectables
LNP
Early De-risking & Optimization
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.
Latest briefing from the Knowledge Center
Publication
Systematic Development of a Detergent Toolbox as an Alternative to Triton X-100
In biomanufacturing, detergents are essential for inactivating enveloped viruses during protein...
White paper
Transferring your cell line with confidence
This white paper explores flexible, data-driven strategies that help streamline biologics...
man working with microscope in lab,Process Development,Biologics_Slough_18,,lab in slough,tech working in lab with computer,male tech pipetting,tech holding vial,tech working,Cell Iine process development,biologics lab worker, ,Biologics_Slough_29,Biologics , Biologics Slough
Article
Partnering for Innovation: Lonza Supports a UK Biotech Developing an Entirely New Modality with...
Epsilogen CEO, Tim Wilson, shares his company’s experience finding the right CDMO partner, willing...
Article
Q&A: Getting it right first time - the importance of early expression vector design
In this interview, Lonza’s Dr. Peter O’Callaghan (Senior Director, Head of Expression System...
Technical/Service brief
GS Gene Expression System: reliability today, innovation for tomorrow
Emerging and small biotechs play a critical role in driving scientific innovation, often advancing...
Webinar (on-demand)
Future-proofing gene therapy: scalable AAV solutions and non-viral innovations
As gene therapy moves toward broader commercialization, the pressure to streamline production and...
Article
The Evolving Landscape of ADC Analytical Development
Lentivirus modeled above hand
White paper
Xcite®: an optimized transient transfection platform to accelerate your AAV program from gene to...
Unlock the full potential of your AAV program with Xcite®: a proven path from gene to GMP by being...
Lonza Bend Solid Form Services
Webinar (on-demand)
Amorphous Solid Dispersions (ASDs): Pre-clinical to Commercial Capabilities
Is your drug candidate struggling with solubility, slowing down its path to market?...
Capsule services
White paper
Unlock key insights of end-to-end regulatory CDMO solutions
Navigating the complex world of drug development and regulatory approval just got easier. Our recent...
Webinar (on-demand)
Lonza's integrated ADC offering: From concept to commercialization
As the Antibody-Drug Conjugate (ADC) market continues its robust expansion, the demand for...